Responses

Download PDFPDF
Still no place for depot triamcinolone in hay fever?
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Yes, an important place for depot triamcinolone in hay fever!
    • J. Alexander de Ru, otorhinolaryngologist Central Military Hospital
    • Other Contributors:
      • Ahmed B. Bayoumy, Resident

    We commend the author’s endeavours to present an unbiased review concerning depot triamcinolone. However, this review cannot be judged a total success; there are numerous flaws that cry out to be corrected. The most important issue is the excessive focus on potential side effects, that are generally regarded as of minor significance.
    We understand that this is a somewhat lengthy comment, but since the journal states that ‘critique and disagreement are important features of science’, we hope that we are allowed to express our opinion in order to be able to promote further debate.

    The title, negatively framed, states ‘Still no place for depot triamcinolone in hay fever?’ and we get the feeling that the author already skipped the question mark and directly continued with the key learning point that ‘in 1999, Drug and Therapeutics Bulletin (DTB) noted that despite the likelihood that a single injection of triamcinolone will relieve hay fever symptoms, there was uncertainty about the efficacy and safety of repeated administration’.1
    This notion is too easily repeated in the current conclusion. The first part of the first sentence of the conclusion section informs us again that a single injection of triamcinolone has likelihood that it will relieve hay fever symptoms. The fact that it probably causes symptom reduction should be enough reason to explore the possible indications for this therapy.
    Therefore, the only logical conclusion should have been that...

    Show More
    Conflict of Interest:
    None declared.